|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $487,342 and $13,000 at December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Factor receivables, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Factor loan payable | ||||||||||||||||||||
| Related party payables | ||||||||||||||||||||
| Short term lease liability | ||||||||||||||||||||
| Short term loan payable | ||||||||||||||||||||
| Warrant and preferred investment option liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long term lease liability | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity (Deficit) | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Common stock, $0.0001 par value, 200,000,000 shares authorized, 567,927 shares and 216,600 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Shareholders’ Equity (Deficit) | ||||||||||||||||||||
| Total Shareholders’ Equity (Deficit) | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity (Deficit) | ||||||||||||||||||||
Loading...
